Croatia vs United Kingdom: Immunization, Hib3 (% of children ages 12-23 months)
Croatia
92.0%
in 2024
United Kingdom
92.0%
in 2024
Croatia rank
84th
United Kingdom rank
84th
Immunization, Hib3 (% of children ages 12-23 months) over time
- Croatia
- United Kingdom
How they compare
Croatia currently reports 92.0% against 92.0% in United Kingdom, a difference of 0.0%.
The two have swapped places 4 times across 23 shared years of data; in 2002 it was United Kingdom ahead.
Croatia ranks 84th and United Kingdom ranks 84th of 191 countries.
Across the 3 decades both report, Croatia averaged higher in 2 and United Kingdom in 1.
Head to head by decade
| Decade | Croatia | United Kingdom | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 93.6% | 91.8% | 1.9% | Croatia |
| 2010s | 94.7% | 94.4% | 0.3% | Croatia |
| 2020s | 92.0% | 92.4% | 0.4% | United Kingdom |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Croatia or United Kingdom?
- Croatia, at 92.0% against 92.0% in United Kingdom as of 2024.
- What is the difference in immunization, hib3 between Croatia and United Kingdom?
- 0.0%, with Croatia ahead.
- How many years of comparable data are there for Croatia and United Kingdom?
- 23 years are reported by both, from 2002 to 2024.
- How do Croatia and United Kingdom rank globally for immunization, hib3?
- Croatia ranks 84th and United Kingdom ranks 84th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.